Ahboucha S, Jiang W, Chatauret N, Mamer O, Baker GB, Butterworth RF (2008) Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis. Neurogastroenterol Motil 20:949–957. https://doi.org/10.1111/j.1365-2982.2008.01132.x

Article  CAS  PubMed  Google Scholar 

Alam I, Razaullah, Haider I, Humayun M, Taqweem MA (2005) Spectrum of precipitating factors of hepatic encephalopathy in liver cirrhosis. Pak J Med Res 44:96–100, n.d

Google Scholar 

Amodio P, Del Piccolo F, Pettenò E, Mapelli D, Angeli P, Iemmolo R, Muraca M, Musto C, Gerunda G, Rizzo C, Merkel C, Gatta A (2001) Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 35:37–45. https://doi.org/10.1016/S0168-8278(01)00129-5

Article  CAS  PubMed  Google Scholar 

Bajaj JS, Sanyal AJ, Bell D, Gilles H, Heuman DM (2010) Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment Pharmacol Ther 31:1012–1017. https://doi.org/10.1111/j.1365-2036.2010.04257.x

Article  CAS  PubMed  Google Scholar 

Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, Stravitz TR, Luketic V, Fuchs M, White MB, Bell DE, Gilles H, Morton K, Noble N, Puri P, Sanyal AJ (2011) The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 106:1646–1653. https://doi.org/10.1038/ajg.2011.157

Article  PubMed  PubMed Central  Google Scholar 

Balata S, Damink O, Ferguson SWM, Marshall K, Hayes I, Deutz PC, Williams NEP, Wardlaw R, Jalan J, R (2003) Induced hyperammonemia alters neuropsychology, brain Mr spectroscopy and magnetization transfer in cirrhosis. Hepatology 37:931–939. https://doi.org/10.1053/jhep.2003.50156

Article  CAS  PubMed  Google Scholar 

Bawankule S, Kumar S, Gaidhane A, Quazi M, Singh A (2019) Clinical profile of patients with hepatic encephalopathy in cirrhosis of liver. J Datta Meghe Inst Med Sci Univ 14:130. https://doi.org/10.4103/jdmimsu.jdmimsu_88_18

Article  Google Scholar 

Berry PA, Antoniades CG, Hussain MJ, McPhail MJW, Bernal W, Vergani D, Wendon JA (2010) Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis. Liver Int 30:733–740. https://doi.org/10.1111/j.1478-3231.2010.02219.x

Article  CAS  PubMed  Google Scholar 

Bustamante J, Rimola A, Ventura P-J, Navasa M, Cirera I, Reggiardo V, Rodés J (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890–895. https://doi.org/10.1016/S0168-8278(99)80144-5

Article  CAS  PubMed  Google Scholar 

Butterworth RF (2011) Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 53:1372–1376. https://doi.org/10.1002/hep.24228

Article  PubMed  Google Scholar 

Christensen E, Krintel JJ, Hansen SM, Johansen JK, Juhl E (1989) Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis: survival and prognostic factors. Scand J Gastroenterol 24:999–1006. https://doi.org/10.3109/00365528909089247

Article  CAS  PubMed  Google Scholar 

Cordoba J, Ventura-Cots M, Simón-Talero M, Amorós À, Pavesi M, Vilstrup H, Angeli P, Domenicali M, Ginés P, Bernardi M, Arroyo V (2014) Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 60:275–281. https://doi.org/10.1016/j.jhep.2013.10.004

Article  PubMed  Google Scholar 

Devrajani BR, Shah SZA, Devrajani T, Kumar D (2009) Precipitating factors of hepatic encephalopathy at a tertiary care hospital Jamshoro, Hyderabad. JPMA J Pak Med Assoc 59:683–686

PubMed  Google Scholar 

Duchini A, Govindarajan S, Santucci M, Zampi G, Hofman FM (1996) Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Investig Med Off Publ Am Fed Clin Res 44:474–482

CAS  Google Scholar 

Ferenci P (2017) Hepatic encephalopathy. Gastroenterol Rep 5:138–147. https://doi.org/10.1093/gastro/gox013

Article  Google Scholar 

Goral V, Atayan Y, Kaplan A (2011) The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α? Hepatogastroenterology 58:943–948

PubMed  Google Scholar 

Jain L, Sharma BC, Sharma P, Srivastava S, Agrawal A, Sarin SK (2012) Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Dig Liver Dis 44:1027–1031. https://doi.org/10.1016/j.dld.2012.07.002

Article  CAS  PubMed  Google Scholar 

Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A (2022) L-ornithine L‐aspartate in acute treatment of severe hepatic encephalopathy: a double‐blind randomized controlled trial. Hepatology 75:1194–1203. https://doi.org/10.1002/hep.32255

Article  CAS  PubMed  Google Scholar 

KK SK, SM S, Valliyot B, Joy V, Beevi K, Balakrishnan S (2017) Study to assess the changing pattern of clinical profile and determine the prognosis in hepatic encephalopathy. Int J Res Med Sci 5:424. https://doi.org/10.18203/2320-6012.ijrms20170030

Krabbe KS, Reichenberg A, Yirmiya R, Smed A, Pedersen BK, Bruunsgaard H (2005) Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun 19:453–460. https://doi.org/10.1016/j.bbi.2005.04.010

Article  CAS  PubMed  Google Scholar 

Labenz C, Toenges G, Huber Y, Nagel M, Marquardt JU, Schattenberg JM, Galle PR, Labenz J, Wörns M (2019) Raised serum interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy. Aliment Pharmacol Ther 50:1112–1119. https://doi.org/10.1111/apt.15515

Article  CAS  PubMed  Google Scholar 

Landis CS, Ghabril M, Rustgi V, Di Bisceglie AM, Maliakkal B, Rockey DC, Vierling JM, Bajaj J, Rowell R, Santoro M, Enriquez A, Jurek M, Mokhtarani M, Coakley DF, Scharschmidt BF (2016) Prospective multicenter observational study of overt hepatic encephalopathy. Dig Dis Sci 61:1728–1734. https://doi.org/10.1007/s10620-016-4031-7

Article  CAS  PubMed  Google Scholar 

Lee MD, Zentella A, Vine W, Pekala PH, Cerami A (1987) Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. Proc Natl Acad Sci U S A 84:2590–2594. https://doi.org/10.1073/pnas.84.9.2590

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39:1441–1449. https://doi.org/10.1002/hep.20194

Article  PubMed  Google Scholar 

Luo M, Li L, Yang E-N, Dai C-Y, Liang S-R, Cao W-K (2013) Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis. Clin Res Hepatol Gastroenterol 37:384–390. https://doi.org/10.1016/j.clinre.2012.08.007

Article  CAS  PubMed  Google Scholar 

Manzhalii E, Virchenko O, Falalyeyeva T, Moiseienko V, Nykula T, Kondratiuk V, Savchuk O, Beregova T, Stremmel W (2019) Hepatic encephalopathy aggravated by systemic inflammation. Dig Dis 37:509–517. https://doi.org/10.1159/000500717

Article  PubMed  Google Scholar 

Maqsood S, Saleem A, Iqbal A, Butt JA (2006) Precipitating factors of hepatic encephalopathy: experience at Pakistan Institute of Medical Sciences Islamabad. J Ayub Med Coll Abbottabad JAMC 18:58–62

PubMed  Google Scholar 

Marini JC, Broussard SR (2006) Hyperammonemia increases sensitivity to LPS. Mol Genet Metab 88:131–137. https://doi.org/10.1016/j.ymgme.2005.12.013

Article  CAS  PubMed  Google Scholar 

Merkel C, Bolognesi M, Angeli P, Noventa F, Caregaro L, Sacerdoti D, Gatta A (1989) Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding. Am J Gastroenterol 84:717–722

CAS  PubMed  Google Scholar 

Montagnese S, Rautou P-E, Romero-Gómez M, Larsen FS, Shawcross DL, Thabut D, Vilstrup H, Weissenborn K (2022) EASL clinical practice guidelines on the management of hepatic encephalopathy. J Hepatol 77:807–824. https://doi.org/10.1016/j.jhep.2022.06.001

Article  Google Scholar 

Montoliu C, Piedrafita B, Serra MA, Del Olmo JA, Urios A, Rodrigo JM, Felipo V (2009) IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 43:272–279. https://doi.org/10.1097/MCG.0b013e31815e7f58

Article  CAS  PubMed